| Bioactivity | 42-(2-Tetrazolyl)rapamycin is a prodrug compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor. | |||||||||
| Name | 42-(2-Tetrazolyl)rapamycin | |||||||||
| CAS | 221877-56-1 | |||||||||
| Formula | C52H79N5O12 | |||||||||
| Molar Mass | 966.21 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Karl W. Mollison, et al. Compounds and methods for treatment and prevention of diseases. US 20080171763 A1. [2]. Ballou LM, et al. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008 Nov;1(1-4):27-36. |
42-(2-Tetrazolyl)rapamycin
CAS: 221877-56-1 F: C52H79N5O12 W: 966.21
42-(2-Tetrazolyl)rapamycin is a prodrug compound of a rapamycin analog extracted from patent US 20080171763 A1, Example
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.